Eurofins Scientific SE (EPA:ERF)

Market Cap	10.85B
Revenue (ttm)	6.95B
Net Income (ttm)	356.30M
Shares Out	179.65M
EPS (ttm)	1.83
PE Ratio	33.02
Forward PE	15.75
Dividend	0.60 (0.99%)
Ex-Dividend Date	Apr 28, 2025

Volume	424,518
Average Volume	385,900
Open	59.38
Previous Close	60.42
Day's Range	59.28 - 60.56
52-Week Range	39.47 - 60.72
Beta	0.79
RSI	70.55
Earnings Date	Jul 23, 2025

About Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, training, advisory, and labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include susta...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1987
• Employees: 62,696
• Stock Exchange: Euronext Paris
• Ticker Symbol: ERF

Financial Performance

In 2024, Eurofins Scientific SE's revenue was 6.95 billion, an increase of 6.70% compared to the previous year's 6.51 billion. Earnings were 356.30 million, an increase of 38.91%.